Company profile
Bottmedical AG
Bottmedical - founded by scientists, supported by international investors, driven by young talents! Bottmedical AG was founded as a start-up from the University of Basel in 2019. Their academic research experience ultimately built the basis for combining a novel biopolymer with cinnamon based antimicrobials to create reloadable and antibacterial invisible dental appliances - the CINNA technology. Today, with 3 patents, more than 30 partner clinics, and 2 certified products under their belt, Bottmedical is actively delivering new ways of improving oral hygiene to the world. The future is even more ambitious, clinical validation starting in 2023 aims to prove the potential of the technology as a personalized drug delivery device for preventive oral health.
Source: startup.ch
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
